Home > Insider Trading > Filing (0000937556-19-000154)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
937556	Masimo Corp	MASI	Electromedical & Electrotherapeutic Apparatus (3845)	330368882

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403400	Yongsam Lee	C/O Masimo Corporation 52 Discovery Irvine CA 92618	Evp & Cio	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-08-12	3,857	$21.97	76,857	No	4	M	Direct
Common Stock	Disposition	2019-08-12	3,857	$153.35	73,000	No	4	S	Direct
Common Stock	Acquisiton	2019-08-13	1,143	$21.97	74,143	No	4	M	Direct
Common Stock	Disposition	2019-08-13	1,143	$153.62	73,000	No	4	S	Direct
Common Stock	Acquisiton	2019-08-13	3,838	$28.03	76,838	No	4	M	Direct
Common Stock	Disposition	2019-08-13	3,838	$153.62	73,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2019-08-12	3,857	$21.97	3,857	$21.97
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2019-08-13	1,143	$21.97	1,143	$21.97
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2019-08-13	3,838	$28.03	3,838	$28.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,143	2014-05-28	2023-05-28	No	4	M	Direct
0	2014-05-28	2023-05-28	No	4	M	Direct
26,162	2015-02-18	2024-02-18	No	4	M	Direct

Footnotes

The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 23, 2019, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $151.965 per share to a high of $154.565 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $151.94 per share to a high of $155.06 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on May 28, 2013 and was exercisable as the option vested. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
This option was granted on February 18, 2014 and was exercisable as the option vested. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.